Deltec Asset Management LLC Ocular Therapeutix, Inc Transaction History

Deltec Asset Management LLC

  • $478 Million
  • Q3 2024

A detailed history of Deltec Asset Management LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Deltec Asset Management LLC holds 2,600,073 shares of OCUL stock, worth $27.4 Million. This represents 4.74% of its overall portfolio holdings.

Number of Shares
2,600,073
Previous 2,590,265 0.38%
Holding current value
$27.4 Million
Previous $17.7 Million 27.67%
% of portfolio
4.74%
Previous 3.55%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024
BUY
$6.45 - $9.23 $63,261 - $90,527
9,808 Added 0.38%
2,600,073 $22.6 Million
Q2 2024

Jul 16, 2024
BUY
$4.2 - $8.69 $949,960 - $1.97 Million
226,181 Added 9.57%
2,590,265 $17.7 Million
Q1 2024

Apr 17, 2024
SELL
$3.85 - $10.93 $306,163 - $869,186
-79,523 Reduced 3.25%
2,364,084 $21.5 Million
Q4 2023

Jan 22, 2024
BUY
$2.08 - $4.52 $794,164 - $1.73 Million
381,810 Added 18.52%
2,443,607 $10.9 Million
Q3 2023

Oct 23, 2023
BUY
$3.14 - $5.04 $273,180 - $438,480
87,000 Added 4.41%
2,061,797 $6.47 Million
Q2 2023

Jul 18, 2023
BUY
$4.6 - $7.64 $281,451 - $467,453
61,185 Added 3.2%
1,974,797 $10.2 Million
Q1 2023

Apr 17, 2023
BUY
$2.79 - $6.27 $169,260 - $380,382
60,667 Added 3.27%
1,913,612 $10.1 Million
Q4 2022

Jan 25, 2023
SELL
$2.61 - $4.41 $1.23 Million - $2.08 Million
-470,728 Reduced 20.26%
1,852,945 $0
Q3 2022

Oct 26, 2022
BUY
$4.09 - $6.5 $1.04 Million - $1.65 Million
254,360 Added 12.29%
2,323,673 $9.64 Million
Q2 2022

Jul 18, 2022
SELL
$3.01 - $5.22 $21,070 - $36,540
-7,000 Reduced 0.34%
2,069,313 $8.32 Million
Q1 2022

Apr 11, 2022
SELL
$4.83 - $7.35 $91,770 - $139,650
-19,000 Reduced 0.91%
2,076,313 $10.3 Million
Q4 2021

Jan 25, 2022
SELL
$6.16 - $12.07 $332,640 - $651,780
-54,000 Reduced 2.51%
2,095,313 $14.6 Million
Q3 2021

Oct 13, 2021
SELL
$9.7 - $14.34 $174,600 - $258,120
-18,000 Reduced 0.83%
2,149,313 $21.5 Million
Q2 2021

Jul 15, 2021
BUY
$13.43 - $19.16 $953,153 - $1.36 Million
70,972 Added 3.39%
2,167,313 $30.7 Million
Q1 2021

Apr 21, 2021
SELL
$15.82 - $22.11 $1.14 Million - $1.6 Million
-72,232 Reduced 3.33%
2,096,341 $34.4 Million
Q4 2020

Jan 20, 2021
SELL
$7.91 - $22.95 $2.4 Million - $6.97 Million
-303,494 Reduced 12.28%
2,168,573 $44.9 Million
Q3 2020

Oct 23, 2020
BUY
$7.36 - $9.87 $1.04 Million - $1.4 Million
141,800 Added 6.09%
2,472,067 $18.8 Million
Q2 2020

Jul 29, 2020
BUY
$4.67 - $8.95 $1.2 Million - $2.3 Million
256,548 Added 12.37%
2,330,267 $19.4 Million
Q1 2020

Apr 22, 2020
SELL
$3.95 - $7.4 $194,889 - $365,108
-49,339 Reduced 2.32%
2,073,719 $10.3 Million
Q4 2019

Jan 27, 2020
BUY
$2.57 - $4.73 $294,455 - $541,935
114,574 Added 5.7%
2,123,058 $8.39 Million
Q3 2019

Oct 24, 2019
BUY
$3.04 - $5.32 $1.8 Million - $3.15 Million
592,237 Added 41.82%
2,008,484 $6.11 Million
Q2 2019

Jul 29, 2019
BUY
$2.46 - $4.52 $1.46 Million - $2.67 Million
591,500 Added 71.72%
1,416,247 $6.23 Million
Q1 2019

Apr 22, 2019
BUY
$3.51 - $4.77 $351,000 - $476,999
100,000 Added 13.8%
824,747 $3.27 Million
Q4 2018

Jan 23, 2019
BUY
$3.87 - $7.11 $405,583 - $745,142
104,802 Added 16.91%
724,747 $2.89 Million
Q3 2018

Oct 18, 2018
BUY
$5.42 - $6.99 $471,317 - $607,843
86,959 Added 16.32%
619,945 $4.27 Million
Q2 2018

Aug 07, 2018
SELL
$5.99 - $8.17 $318,985 - $435,077
-53,253 Reduced 9.08%
532,986 $3.6 Million
Q1 2018

May 11, 2018
BUY
$4.66 - $7.08 $1.73 Million - $2.63 Million
372,000 Added 173.64%
586,239 $3.82 Million
Q4 2017

Feb 05, 2018
SELL
$3.73 - $6.37 $356,095 - $608,131
-95,468 Reduced 30.83%
214,239 $953,000
Q3 2017

Oct 30, 2017
BUY
$5.28 - $6.88 $1.64 Million - $2.13 Million
309,707
309,707 $1.91 Million

Others Institutions Holding OCUL

# of Institutions
156
Shares Held
139M
Call Options Held
86.4K
Put Options Held
263K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $810M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Deltec Asset Management LLC Portfolio

Follow Deltec Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deltec Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Deltec Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email